Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Women's Health | 9 | 2024 | 399 | 3.380 |
Why?
|
Reproductive Health | 4 | 2022 | 24 | 1.910 |
Why?
|
Students | 8 | 2022 | 205 | 1.910 |
Why?
|
Social Justice | 3 | 2023 | 30 | 1.870 |
Why?
|
Pregnancy | 25 | 2024 | 2320 | 1.840 |
Why?
|
Sex Offenses | 8 | 2018 | 45 | 1.650 |
Why?
|
Female | 62 | 2024 | 29603 | 1.640 |
Why?
|
Humans | 85 | 2024 | 57062 | 1.580 |
Why?
|
Contraception | 4 | 2017 | 64 | 1.510 |
Why?
|
Intimate Partner Violence | 5 | 2018 | 26 | 1.470 |
Why?
|
Sexually Transmitted Diseases | 7 | 2018 | 93 | 1.470 |
Why?
|
Hot Flashes | 2 | 2024 | 91 | 1.400 |
Why?
|
Contraception Behavior | 4 | 2014 | 35 | 1.270 |
Why?
|
Adolescent Behavior | 5 | 2018 | 189 | 1.270 |
Why?
|
Menopause | 2 | 2024 | 247 | 1.260 |
Why?
|
Universities | 10 | 2022 | 148 | 1.230 |
Why?
|
Nurse's Role | 4 | 2024 | 120 | 1.230 |
Why?
|
Safe Sex | 4 | 2018 | 25 | 1.230 |
Why?
|
Sexual Behavior | 7 | 2015 | 186 | 1.210 |
Why?
|
Papillomavirus Infections | 6 | 2016 | 120 | 1.190 |
Why?
|
Alcohol Drinking | 4 | 2018 | 298 | 1.190 |
Why?
|
Spouse Abuse | 5 | 2014 | 42 | 1.100 |
Why?
|
Health Knowledge, Attitudes, Practice | 7 | 2023 | 728 | 1.070 |
Why?
|
Analgesics, Opioid | 3 | 2020 | 481 | 1.040 |
Why?
|
Benzimidazoles | 2 | 2016 | 57 | 1.010 |
Why?
|
Mass Screening | 7 | 2020 | 626 | 1.000 |
Why?
|
Papillomavirus Vaccines | 6 | 2016 | 68 | 0.970 |
Why?
|
Patient Advocacy | 1 | 2024 | 29 | 0.960 |
Why?
|
Politics | 1 | 2024 | 29 | 0.960 |
Why?
|
Decision Making | 5 | 2018 | 374 | 0.930 |
Why?
|
Health Promotion | 2 | 2023 | 494 | 0.930 |
Why?
|
Dyspareunia | 4 | 2024 | 8 | 0.930 |
Why?
|
Breast Feeding | 2 | 2024 | 136 | 0.920 |
Why?
|
Sexual Partners | 6 | 2019 | 74 | 0.910 |
Why?
|
Fructose | 2 | 2014 | 40 | 0.890 |
Why?
|
Pregnancy in Adolescence | 2 | 2015 | 22 | 0.880 |
Why?
|
Education, Nursing, Graduate | 1 | 2023 | 44 | 0.880 |
Why?
|
Women's Rights | 1 | 2023 | 6 | 0.880 |
Why?
|
Endometriosis | 2 | 2020 | 22 | 0.860 |
Why?
|
Motivation | 2 | 2023 | 264 | 0.860 |
Why?
|
United States | 20 | 2023 | 7262 | 0.850 |
Why?
|
Nurses | 1 | 2023 | 96 | 0.830 |
Why?
|
Adolescent | 23 | 2018 | 5782 | 0.810 |
Why?
|
Vaccines | 1 | 2023 | 95 | 0.800 |
Why?
|
Mentoring | 1 | 2022 | 46 | 0.790 |
Why?
|
Neonatal Abstinence Syndrome | 2 | 2019 | 32 | 0.790 |
Why?
|
Mentors | 1 | 2022 | 112 | 0.790 |
Why?
|
Nursing Research | 3 | 2017 | 39 | 0.780 |
Why?
|
Publishing | 1 | 2022 | 87 | 0.770 |
Why?
|
Patient-Centered Care | 1 | 2024 | 242 | 0.770 |
Why?
|
Communication | 4 | 2022 | 520 | 0.760 |
Why?
|
Antiviral Agents | 2 | 2015 | 311 | 0.750 |
Why?
|
Rape | 2 | 2011 | 14 | 0.750 |
Why?
|
Public Health | 2 | 2022 | 176 | 0.730 |
Why?
|
Nasal Sprays | 1 | 2020 | 2 | 0.730 |
Why?
|
Benzaldehydes | 1 | 2020 | 3 | 0.730 |
Why?
|
Depressive Disorder, Treatment-Resistant | 1 | 2020 | 6 | 0.720 |
Why?
|
Nurse Practitioners | 4 | 2020 | 115 | 0.710 |
Why?
|
Pyrazines | 1 | 2020 | 32 | 0.710 |
Why?
|
Social Media | 1 | 2022 | 108 | 0.700 |
Why?
|
Ketamine | 1 | 2020 | 30 | 0.700 |
Why?
|
Pyrazoles | 1 | 2020 | 68 | 0.690 |
Why?
|
Pain | 4 | 2020 | 403 | 0.690 |
Why?
|
Focus Groups | 4 | 2017 | 285 | 0.690 |
Why?
|
Anemia, Sickle Cell | 1 | 2020 | 64 | 0.680 |
Why?
|
Depression, Postpartum | 2 | 2019 | 161 | 0.680 |
Why?
|
Adult | 26 | 2020 | 15129 | 0.680 |
Why?
|
Hydrocarbons, Fluorinated | 1 | 2019 | 9 | 0.680 |
Why?
|
beta-Cyclodextrins | 1 | 2019 | 25 | 0.680 |
Why?
|
Pregnanolone | 1 | 2019 | 27 | 0.670 |
Why?
|
Pyrimidines | 1 | 2019 | 115 | 0.650 |
Why?
|
Abdominal Pain | 1 | 2019 | 92 | 0.640 |
Why?
|
Risk-Taking | 3 | 2014 | 157 | 0.640 |
Why?
|
Counterfeit Drugs | 1 | 2018 | 1 | 0.640 |
Why?
|
Violence | 3 | 2014 | 148 | 0.620 |
Why?
|
Self Report | 3 | 2017 | 360 | 0.610 |
Why?
|
Mothers | 2 | 2023 | 253 | 0.600 |
Why?
|
Child, Hospitalized | 1 | 2017 | 14 | 0.600 |
Why?
|
Young Adult | 17 | 2018 | 4128 | 0.590 |
Why?
|
Dronabinol | 1 | 2017 | 29 | 0.580 |
Why?
|
Ovary | 1 | 2017 | 105 | 0.580 |
Why?
|
Opiate Substitution Treatment | 1 | 2019 | 186 | 0.580 |
Why?
|
Tobacco Use | 1 | 2017 | 33 | 0.570 |
Why?
|
Obesity | 2 | 2016 | 1182 | 0.560 |
Why?
|
Uterine Cervical Neoplasms | 2 | 2015 | 141 | 0.560 |
Why?
|
Libido | 1 | 2016 | 3 | 0.560 |
Why?
|
Aspirin | 1 | 2018 | 183 | 0.550 |
Why?
|
Pre-Eclampsia | 1 | 2018 | 86 | 0.550 |
Why?
|
Cannabis | 1 | 2017 | 45 | 0.550 |
Why?
|
Sexual Dysfunctions, Psychological | 1 | 2016 | 12 | 0.550 |
Why?
|
Sex Education | 2 | 2018 | 23 | 0.540 |
Why?
|
Phytotherapy | 1 | 2016 | 53 | 0.540 |
Why?
|
Infertility | 1 | 2016 | 37 | 0.530 |
Why?
|
Vascular Diseases | 1 | 2016 | 65 | 0.530 |
Why?
|
Sexuality | 2 | 2012 | 23 | 0.520 |
Why?
|
Intrauterine Devices | 1 | 2015 | 6 | 0.510 |
Why?
|
Drug Labeling | 1 | 2015 | 27 | 0.510 |
Why?
|
Uridine Monophosphate | 1 | 2015 | 8 | 0.510 |
Why?
|
Fluorenes | 1 | 2015 | 11 | 0.510 |
Why?
|
Domestic Violence | 2 | 2012 | 33 | 0.510 |
Why?
|
Ambulatory Care | 1 | 2017 | 283 | 0.500 |
Why?
|
Administration, Inhalation | 1 | 2015 | 81 | 0.490 |
Why?
|
Lactation | 1 | 2015 | 70 | 0.490 |
Why?
|
New England | 6 | 2018 | 266 | 0.490 |
Why?
|
Prescription Drugs | 1 | 2015 | 49 | 0.490 |
Why?
|
Negotiating | 1 | 2014 | 16 | 0.490 |
Why?
|
Vulva | 1 | 2014 | 17 | 0.480 |
Why?
|
Selective Estrogen Receptor Modulators | 1 | 2014 | 15 | 0.480 |
Why?
|
Tamoxifen | 1 | 2014 | 34 | 0.470 |
Why?
|
Dicyclomine | 1 | 2014 | 1 | 0.470 |
Why?
|
Doxylamine | 1 | 2014 | 1 | 0.470 |
Why?
|
Hyperemesis Gravidarum | 1 | 2014 | 1 | 0.470 |
Why?
|
Pyridoxine | 1 | 2014 | 4 | 0.470 |
Why?
|
Morning Sickness | 1 | 2014 | 3 | 0.470 |
Why?
|
Migraine Disorders | 1 | 2014 | 44 | 0.470 |
Why?
|
Vagina | 1 | 2014 | 81 | 0.470 |
Why?
|
Neuroprotective Agents | 1 | 2014 | 68 | 0.470 |
Why?
|
Research Design | 1 | 2017 | 561 | 0.460 |
Why?
|
Disclosure | 1 | 2014 | 47 | 0.450 |
Why?
|
Opioid-Related Disorders | 1 | 2020 | 450 | 0.450 |
Why?
|
Ceftriaxone | 1 | 2013 | 19 | 0.440 |
Why?
|
Phentermine | 1 | 2013 | 2 | 0.440 |
Why?
|
Hepatitis C | 1 | 2015 | 133 | 0.440 |
Why?
|
Pregnancy, High-Risk | 2 | 2012 | 23 | 0.440 |
Why?
|
Anti-Obesity Agents | 1 | 2013 | 11 | 0.440 |
Why?
|
Benzazepines | 1 | 2013 | 22 | 0.430 |
Why?
|
Antiemetics | 1 | 2014 | 96 | 0.430 |
Why?
|
Condylomata Acuminata | 1 | 2012 | 9 | 0.430 |
Why?
|
Catechin | 1 | 2012 | 31 | 0.420 |
Why?
|
Family Planning Services | 2 | 2012 | 21 | 0.410 |
Why?
|
Battered Women | 1 | 2012 | 12 | 0.410 |
Why?
|
Patient Education as Topic | 4 | 2018 | 444 | 0.410 |
Why?
|
Health Surveys | 3 | 2014 | 307 | 0.410 |
Why?
|
Substance-Related Disorders | 2 | 2017 | 676 | 0.400 |
Why?
|
Women | 2 | 2014 | 45 | 0.400 |
Why?
|
Drug Combinations | 3 | 2019 | 127 | 0.390 |
Why?
|
Progesterone | 1 | 2012 | 161 | 0.390 |
Why?
|
Feminism | 1 | 2011 | 1 | 0.390 |
Why?
|
Social Control, Formal | 1 | 2011 | 20 | 0.380 |
Why?
|
Nursing Evaluation Research | 1 | 2010 | 38 | 0.370 |
Why?
|
Psychiatric Nursing | 1 | 2010 | 13 | 0.370 |
Why?
|
Gonorrhea | 1 | 2013 | 196 | 0.370 |
Why?
|
Insulin | 1 | 2015 | 692 | 0.370 |
Why?
|
Drug Resistance, Multiple | 1 | 2010 | 34 | 0.370 |
Why?
|
Infant, Newborn | 3 | 2020 | 1292 | 0.370 |
Why?
|
Premature Birth | 1 | 2012 | 107 | 0.370 |
Why?
|
Hospitals, Psychiatric | 1 | 2010 | 51 | 0.370 |
Why?
|
Delivery of Health Care | 3 | 2023 | 411 | 0.360 |
Why?
|
Time Factors | 1 | 2017 | 3457 | 0.350 |
Why?
|
Postpartum Period | 3 | 2020 | 196 | 0.350 |
Why?
|
Child | 6 | 2023 | 4223 | 0.340 |
Why?
|
Patient Selection | 1 | 2012 | 420 | 0.340 |
Why?
|
Cross Infection | 1 | 2010 | 138 | 0.340 |
Why?
|
Quality of Life | 2 | 2020 | 973 | 0.330 |
Why?
|
Practice Guidelines as Topic | 1 | 2013 | 677 | 0.330 |
Why?
|
Intrauterine Devices, Copper | 1 | 2008 | 2 | 0.320 |
Why?
|
Intrauterine Devices, Medicated | 1 | 2008 | 7 | 0.310 |
Why?
|
Forensic Nursing | 3 | 2012 | 3 | 0.310 |
Why?
|
Vaccination | 2 | 2023 | 319 | 0.300 |
Why?
|
Anti-Bacterial Agents | 1 | 2013 | 652 | 0.300 |
Why?
|
Methadone | 2 | 2019 | 124 | 0.290 |
Why?
|
Risk Reduction Behavior | 3 | 2018 | 126 | 0.270 |
Why?
|
Risk Factors | 9 | 2022 | 4816 | 0.270 |
Why?
|
HIV Infections | 4 | 2020 | 901 | 0.270 |
Why?
|
Pediatric Nursing | 2 | 2017 | 11 | 0.260 |
Why?
|
United States Food and Drug Administration | 2 | 2016 | 91 | 0.250 |
Why?
|
Drug Interactions | 2 | 2016 | 111 | 0.250 |
Why?
|
Attitude of Health Personnel | 2 | 2024 | 547 | 0.250 |
Why?
|
Risk | 2 | 2018 | 365 | 0.240 |
Why?
|
Buprenorphine | 2 | 2019 | 183 | 0.240 |
Why?
|
Urinary Incontinence | 1 | 2024 | 33 | 0.240 |
Why?
|
Middle Aged | 9 | 2024 | 15409 | 0.240 |
Why?
|
Administration, Oral | 2 | 2016 | 334 | 0.240 |
Why?
|
Male | 14 | 2020 | 26215 | 0.240 |
Why?
|
Estrogen Replacement Therapy | 1 | 2024 | 97 | 0.230 |
Why?
|
Doulas | 1 | 2023 | 5 | 0.230 |
Why?
|
Nurse-Patient Relations | 2 | 2018 | 41 | 0.230 |
Why?
|
Urban Population | 2 | 2016 | 182 | 0.220 |
Why?
|
Emigrants and Immigrants | 1 | 2023 | 35 | 0.220 |
Why?
|
Pregnancy Complications | 2 | 2019 | 384 | 0.220 |
Why?
|
Needs Assessment | 2 | 2017 | 176 | 0.220 |
Why?
|
Evidence-Based Practice | 1 | 2023 | 80 | 0.220 |
Why?
|
Maternal Health Services | 1 | 2024 | 64 | 0.220 |
Why?
|
Life Style | 2 | 2016 | 333 | 0.210 |
Why?
|
Fellowships and Scholarships | 1 | 2023 | 88 | 0.210 |
Why?
|
Health Policy | 1 | 2024 | 178 | 0.210 |
Why?
|
Cultural Diversity | 1 | 2023 | 46 | 0.210 |
Why?
|
Fathers | 2 | 2019 | 25 | 0.210 |
Why?
|
Emergency Nursing | 2 | 2012 | 17 | 0.210 |
Why?
|
Social Determinants of Health | 1 | 2024 | 107 | 0.210 |
Why?
|
Cross-Sectional Studies | 5 | 2017 | 2376 | 0.200 |
Why?
|
Pilot Projects | 3 | 2024 | 883 | 0.200 |
Why?
|
Risk Assessment | 4 | 2018 | 1835 | 0.200 |
Why?
|
Social Support | 1 | 2024 | 352 | 0.200 |
Why?
|
Food Supply | 1 | 2022 | 73 | 0.200 |
Why?
|
Crime | 1 | 2012 | 63 | 0.190 |
Why?
|
Treatment Outcome | 3 | 2019 | 4824 | 0.190 |
Why?
|
Surveys and Questionnaires | 6 | 2020 | 2480 | 0.190 |
Why?
|
Heroin | 1 | 2020 | 11 | 0.190 |
Why?
|
Hematologic Agents | 1 | 2020 | 4 | 0.180 |
Why?
|
Courtship | 2 | 2011 | 5 | 0.170 |
Why?
|
Outpatients | 1 | 2020 | 129 | 0.170 |
Why?
|
Dysmenorrhea | 1 | 2019 | 8 | 0.170 |
Why?
|
Hormone Antagonists | 1 | 2019 | 13 | 0.170 |
Why?
|
Administration, Intravenous | 1 | 2019 | 57 | 0.170 |
Why?
|
Morphine | 1 | 2019 | 52 | 0.170 |
Why?
|
Drug Therapy | 1 | 2019 | 59 | 0.160 |
Why?
|
Patient Acceptance of Health Care | 1 | 2023 | 444 | 0.160 |
Why?
|
Sexual Harassment | 1 | 2018 | 14 | 0.160 |
Why?
|
Pharmaceutical Services, Online | 1 | 2018 | 1 | 0.160 |
Why?
|
Organizational Policy | 1 | 2018 | 53 | 0.160 |
Why?
|
Papillomaviridae | 2 | 2015 | 58 | 0.160 |
Why?
|
Antidepressive Agents | 1 | 2020 | 226 | 0.160 |
Why?
|
Adverse Drug Reaction Reporting Systems | 1 | 2018 | 48 | 0.150 |
Why?
|
Hysteroscopy | 1 | 2017 | 3 | 0.150 |
Why?
|
Dizziness | 1 | 2017 | 16 | 0.150 |
Why?
|
Nursing Process | 1 | 2017 | 6 | 0.150 |
Why?
|
Prevalence | 3 | 2017 | 1247 | 0.150 |
Why?
|
Adrenergic alpha-Agonists | 1 | 2016 | 20 | 0.140 |
Why?
|
Paroxetine | 1 | 2016 | 15 | 0.140 |
Why?
|
Nausea | 1 | 2017 | 107 | 0.140 |
Why?
|
Anovulation | 1 | 2016 | 8 | 0.140 |
Why?
|
Homosexuality, Male | 1 | 2016 | 35 | 0.140 |
Why?
|
Serotonin Agents | 1 | 2016 | 10 | 0.140 |
Why?
|
Contraindications | 1 | 2016 | 40 | 0.140 |
Why?
|
Syncope | 1 | 2016 | 37 | 0.140 |
Why?
|
Drug Approval | 1 | 2016 | 27 | 0.140 |
Why?
|
Premenopause | 1 | 2016 | 59 | 0.130 |
Why?
|
Infant | 1 | 2020 | 1497 | 0.130 |
Why?
|
Motivational Interviewing | 1 | 2016 | 41 | 0.130 |
Why?
|
Hypotension | 1 | 2016 | 46 | 0.130 |
Why?
|
Quality of Health Care | 1 | 2020 | 496 | 0.130 |
Why?
|
Prenatal Exposure Delayed Effects | 1 | 2017 | 163 | 0.130 |
Why?
|
Sofosbuvir | 1 | 2015 | 16 | 0.130 |
Why?
|
Behavior Therapy | 1 | 2016 | 163 | 0.120 |
Why?
|
Pregnancy Rate | 1 | 2015 | 33 | 0.120 |
Why?
|
Pregnancy, Unwanted | 1 | 2014 | 10 | 0.120 |
Why?
|
Coercion | 1 | 2015 | 54 | 0.120 |
Why?
|
Interviews as Topic | 2 | 2019 | 466 | 0.120 |
Why?
|
Obstetric Nursing | 1 | 2014 | 1 | 0.120 |
Why?
|
Drug Information Services | 1 | 2014 | 5 | 0.120 |
Why?
|
Atrophy | 1 | 2014 | 58 | 0.120 |
Why?
|
Therapeutic Equivalency | 1 | 2014 | 9 | 0.120 |
Why?
|
Dissociative Disorders | 1 | 2014 | 7 | 0.120 |
Why?
|
Abnormalities, Drug-Induced | 1 | 2014 | 21 | 0.120 |
Why?
|
Feeding Behavior | 1 | 2016 | 315 | 0.110 |
Why?
|
Health Education | 1 | 2015 | 184 | 0.110 |
Why?
|
Hepacivirus | 1 | 2015 | 135 | 0.110 |
Why?
|
Interpersonal Relations | 1 | 2014 | 150 | 0.110 |
Why?
|
Drug Administration Schedule | 1 | 2014 | 272 | 0.110 |
Why?
|
Delayed-Action Preparations | 1 | 2014 | 105 | 0.110 |
Why?
|
Injections, Intramuscular | 1 | 2013 | 70 | 0.110 |
Why?
|
Rural Population | 2 | 2012 | 183 | 0.110 |
Why?
|
Drug Hypersensitivity | 1 | 2013 | 27 | 0.110 |
Why?
|
Ethanol | 1 | 2016 | 301 | 0.110 |
Why?
|
Hypoglycemic Agents | 1 | 2015 | 210 | 0.110 |
Why?
|
Genital Diseases, Female | 1 | 2012 | 16 | 0.110 |
Why?
|
Social Identification | 1 | 2012 | 14 | 0.110 |
Why?
|
Administration, Topical | 1 | 2012 | 51 | 0.110 |
Why?
|
Perception | 1 | 2014 | 178 | 0.110 |
Why?
|
Drug Resistance, Bacterial | 1 | 2013 | 77 | 0.110 |
Why?
|
Administration, Intravaginal | 1 | 2012 | 10 | 0.110 |
Why?
|
Contraception, Postcoital | 1 | 2012 | 4 | 0.100 |
Why?
|
Physical Examination | 1 | 2012 | 101 | 0.100 |
Why?
|
Liver | 1 | 2016 | 749 | 0.100 |
Why?
|
Child Abuse, Sexual | 1 | 2011 | 21 | 0.100 |
Why?
|
Retrospective Studies | 2 | 2014 | 5650 | 0.100 |
Why?
|
Evidence-Based Medicine | 1 | 2013 | 442 | 0.100 |
Why?
|
Pregnancy Trimester, Third | 1 | 2011 | 25 | 0.100 |
Why?
|
Hospital Bed Capacity, 100 to 299 | 1 | 2010 | 1 | 0.100 |
Why?
|
Crime Victims | 1 | 2011 | 32 | 0.090 |
Why?
|
Pregnancy Outcome | 1 | 2012 | 188 | 0.090 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2012 | 797 | 0.090 |
Why?
|
Social Behavior | 1 | 2011 | 85 | 0.090 |
Why?
|
Health Care Surveys | 1 | 2010 | 279 | 0.090 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2015 | 596 | 0.090 |
Why?
|
Exercise | 1 | 2016 | 910 | 0.080 |
Why?
|
Body Mass Index | 1 | 2013 | 899 | 0.080 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2012 | 633 | 0.080 |
Why?
|
Intrauterine Device Expulsion | 1 | 2008 | 2 | 0.080 |
Why?
|
Pelvic Inflammatory Disease | 1 | 2008 | 24 | 0.080 |
Why?
|
Medically Uninsured | 1 | 2008 | 42 | 0.080 |
Why?
|
Uterine Hemorrhage | 1 | 2008 | 20 | 0.080 |
Why?
|
North America | 1 | 2008 | 108 | 0.080 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2015 | 668 | 0.080 |
Why?
|
Parity | 1 | 2008 | 71 | 0.080 |
Why?
|
Safety | 1 | 2008 | 139 | 0.070 |
Why?
|
Health Services Needs and Demand | 1 | 2008 | 209 | 0.070 |
Why?
|
Condoms | 2 | 2018 | 47 | 0.070 |
Why?
|
Postmenopause | 1 | 2008 | 281 | 0.070 |
Why?
|
Diet | 1 | 2011 | 646 | 0.070 |
Why?
|
Counseling | 1 | 2008 | 367 | 0.060 |
Why?
|
Logistic Models | 2 | 2014 | 1243 | 0.060 |
Why?
|
Maternal Health | 1 | 2023 | 13 | 0.060 |
Why?
|
Emergency Service, Hospital | 1 | 2011 | 983 | 0.060 |
Why?
|
Parturition | 1 | 2024 | 51 | 0.060 |
Why?
|
Delivery, Obstetric | 1 | 2024 | 54 | 0.060 |
Why?
|
Qualitative Research | 2 | 2018 | 562 | 0.050 |
Why?
|
Internet | 2 | 2015 | 449 | 0.050 |
Why?
|
Statistics as Topic | 1 | 2012 | 148 | 0.050 |
Why?
|
Socioeconomic Factors | 2 | 2015 | 781 | 0.050 |
Why?
|
Population Surveillance | 1 | 2012 | 207 | 0.050 |
Why?
|
Adaptation, Psychological | 1 | 2012 | 260 | 0.040 |
Why?
|
Multivariate Analysis | 1 | 2012 | 904 | 0.040 |
Why?
|
Evaluation Studies as Topic | 1 | 2019 | 103 | 0.040 |
Why?
|
Sex Factors | 1 | 2012 | 934 | 0.040 |
Why?
|
Father-Child Relations | 1 | 2018 | 7 | 0.040 |
Why?
|
Nuclear Family | 1 | 2018 | 19 | 0.040 |
Why?
|
Stress, Psychological | 1 | 2012 | 436 | 0.040 |
Why?
|
Mass Vaccination | 1 | 2015 | 9 | 0.030 |
Why?
|
Confidence Intervals | 1 | 2015 | 258 | 0.030 |
Why?
|
Unsafe Sex | 1 | 2014 | 27 | 0.030 |
Why?
|
Nursing Staff, Hospital | 1 | 2012 | 70 | 0.030 |
Why?
|
Age Distribution | 1 | 2012 | 262 | 0.030 |
Why?
|
Southeastern United States | 1 | 2011 | 24 | 0.030 |
Why?
|
Incidence | 1 | 2015 | 1188 | 0.020 |
Why?
|
Prenatal Nutritional Physiological Phenomena | 1 | 2011 | 5 | 0.020 |
Why?
|
Boston | 1 | 2009 | 324 | 0.020 |
Why?
|
Referral and Consultation | 1 | 2011 | 396 | 0.020 |
Why?
|
Reproducibility of Results | 1 | 2012 | 1485 | 0.020 |
Why?
|
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 | 1 | 2007 | 8 | 0.020 |
Why?
|
Psychology, Adolescent | 1 | 2007 | 25 | 0.020 |
Why?
|
Massachusetts | 1 | 2012 | 2085 | 0.020 |
Why?
|
Aged | 1 | 2012 | 12582 | 0.010 |
Why?
|